Table 1 Clinicopathological data of the studied cases of invasive ductal breast carcinoma.

From: ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B

Characteristic

No. (%) of patients (n = 495)

Tumour size

T1 (< 2 cm)

190 (38.0)

T2 (2–5 cm)

129 (26.0)

T3 (> 5 cm)

130 (26.0)

T4

46 (9.0)

Tumour stage - pT

1

313 (63.23)

2

152 (30.71)

3

19 (3.84)

4

11 (2.22)

Grading

I

92 (18.59)

II

312 (63.03)

III

91 (18.38)

Nodal status pN

N0

298 (60.20)

N1

167 (33.74)

N2

18 (3.64)

N3

12 (2.42)

ER status

Positive

324 (65.45)

Negative

171 (34.55)

PR status

 

Positive

312 (63.03)

Negative

183 (36.97)

HER2 status

Positive

311 (62.83)

Negative

184 (37.17)

Triple negative status

Positive

40 (8.08)

Negative

455 (91.92)

Back to article page